NCT01357629终止不适用
Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunizations With AFFITOPE AD02 Applied During AFFiRiS002 and AFF004A in Patients With Alzheimer's Disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- Affiris AG
- 入组人数
- 11
- 试验地点
- 2
- 主要终点
- Safety
研究概览
简要总结
This study examines the long term Safety Follow-up of first patients vaccinated with AD02.
详细描述
Patients who have received AD02 during AFF002 and AFF004A will be observed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •participation in AFF002 and AFF004A
排除标准
- •no vaccination with AD02
结局指标
主要结局
Safety
时间窗: up to 2 years
collection and evaluation of AEs, SAEs
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
2 期
Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006Alzheimer´s DiseaseNCT02008513Affiris AG194
已完成
1 期
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.Alzheimer's DiseaseNCT03172117Medipost Co Ltd.36
已完成
不适用
AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01AParkinson's DiseaseNCT01885494Affiris AG30
已完成
不适用
AD01 Follow up Extension VisitAlzheimer´s DiseaseNCT01225809Affiris AG17
已完成
不适用
Long-term Safety and Tolerability of AFFITOPE AD02Alzheimer's DiseaseNCT00711321Affiris AG23